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Background: Even though antiretroviral therapy has reduced
the incidence of cytomegalovirus retinitis (R-CMV), this disorder
continues to be a considerable cause of visual impairment among
AIDS patients. The incidence of R-CMV is increasing in young
patients outside the ﬁrst world who, despite the control of HIV-1
viremia, are blind, either because retinitis has not been diagnosed
or has incorrectly been treated. An insertion/deletion fragment at
the 3’untranslated region of the HLA-C gene has been associated
with progression to AIDS after HIV infection. Thus, the search for
genetic markers associated with disease susceptibility/morbidity
may help to identify AIDS patients prone to develop R-CMV.
Methods & Materials: Four groups of patients were typed for
HLA-C: GI (n=52), consisting of patients with AIDS and R-CMV; GII
(n=170) patients with AIDS without R-CMV; GIII (n=222) encom-
passingGI andGII; andGIV (n=202), healthyHIV- individuals.HLA-C
typingwasperformedusing commercial kits. The allele frequencies
were compared between groups and the etiologic and preventive
fractions were calculated. Intergroup differences were analyzed by
the Fisher exact test and the odds ratio (OR) and 95% conﬁdence
interval (95%CI) were calculated, with the level of signiﬁcance set
at P≤0.05.
Results: The HLA-C*07 allele group was underrepresented in
AIDS patients with R-CMV (OR: 0.4192, 95% CI 0.2246–0.7822,
P=0.0054) when compared to controls or when compared to
AIDS patients without R-CMV (OR: 0.4233, 95% CI 0.2246-0.9782,
P=0.0063), conferring preventive fraction of 0.1553 and 0.1531,
respectively.
Conclusion: The HLA-C*07 allele group was associated with
protection against R-CMV, and the study of HLA-C*07 haplotypes
encompassing the coding and 3′UTR segments may help on dis-
criminating AIDS patients prone to develop R-CMV.
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Background: As of 2012, 3,400000 million people (all ages) are
living with HIV in Nigeria. The estimated new HIV infections is
260,000 and estimated AIDS death is 240,000. The reported num-
ber of adults on ART(Anti-retroviral treatment) was 459,465 and
the ART coverage based on WHO guideline was 36%. The num-
ber of pregnantwomen livingwith HIVwho received antiretroviral
for preventing mother- to-child –transmission was 33,323 and the
percentage coverage was 17%1. Enugu State has the highest preva-
lence(6.5%) of HIV/ AIDS in the South East and the fourth in Nigeria.
To implement the commitments in the 2011 United Nations Polit-
ical Declaration on HIV and AIDS and increase progress towards
universal access to HIV prevention, treatment, care and support,
Nigeria has developed the president’s Comprehensive Response
Plan (PCRP). We determined the implementation of these preven-
tive services by health care providers in Enugu State.
Methods & Materials: I reviewed 2010-2013 HIV/AIDS Surveil-
lancedata of EnuguState.We conducteddescriptive analysis of ART
utilization, PMTCT and HCT services using Microsoft Excel 2007.
Results: The total number of all individuals that accessed HCT
services from 2010 to 2013 was 87,000, 104,344, 161,517, and
113,903 respectively. The total number of HIV positive individu-
als from 2010 to 2013 was 8,965(10.3%), 7695(7.3%), 9233(5.7%),
and6110(5.4%). respectively. The overall total number of individual
newly started on ART from 2010 to 2013 was 15,629. The percent-
age of pregnant women counseled, tested with result was 23,100,
41,000, 45,318, and 38,440 respectively for 2010 -2013 and those
that tested positive are for 2010-2013 are 1,059(4.6%), 1,363(3.3%),
1,845(4.1%), and 1,036(2.7%).Among the pregnant women that
tested positive, the number that are receiving ART for 2010-
2013 are 1,028(92.0%), 1,041(76.4%), 1,640(88.9%), and 719(69.4%)
respectively
Conclusion: The state AIDS and STI control Programme, though
has achieved success in the prevention of HIV/AIDS as evidenced
by decreased percentage of HIV/AIDS positive individuals over the
years under study and decreased percentage of newly diagnosed
HIV positive cases among pregnant women, the State still need to
scale up the ART coverage among pregnant women by increasing
the number of facilities that renders ART services in the state.
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